Cellebrite DI Ltd (CLBT) poses a Brand-New Opportunity for Investors with beta value of 1.49

As on Thursday, Cellebrite DI Ltd (NASDAQ: CLBT) got off with the flyer as it spiked 4.01% to $13.24, before settling in for the price of $12.73 at the close. Taking a more long-term approach, CLBT posted a 52-week range of $6.36-$14.11.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The Technology sector firm’s twelve-monthly sales growth has been 18.79% for the last half of the decade. Nevertheless, stock’s Earnings Per Share (EPS) this year is 52.09%. This publicly-traded company’s shares outstanding now amounts to $203.23 million, simultaneously with a float of $61.29 million. The organization now has a market capitalization sitting at $2.72 billion. At the time of writing, stock’s 50-day Moving Average stood at $12.14, while the 200-day Moving Average is $10.31.

Cellebrite DI Ltd (CLBT) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Software – Infrastructure industry. Cellebrite DI Ltd’s current insider ownership accounts for 70.15%, in contrast to 30.73% institutional ownership.

Cellebrite DI Ltd (CLBT) Earnings and Revenue Records

Cellebrite DI Ltd’s EPS increase for this current 12-month fiscal period is 52.09% and is forecasted to reach 0.25 in the upcoming year.

Cellebrite DI Ltd (NASDAQ: CLBT) Trading Performance Indicators

Let’s observe the current performance indicators for Cellebrite DI Ltd (CLBT). It’s Quick Ratio in the last reported quarter now stands at 1.55. The Stock has managed to achieve an average true range (ATR) of 0.51. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 7.91. Similarly, its price to free cash flow for trailing twelve months is now 28.93.

In the same vein, CLBT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.58, a figure that is expected to reach 0.04 in the next quarter, and analysts are predicting that it will be 0.25 at the market close of one year from today.

Technical Analysis of Cellebrite DI Ltd (CLBT)

Through scrutinizing the latest numbers posted by the [Cellebrite DI Ltd, CLBT], it can be observed that its last 5-days Average volume of 1.05 million was lower the volume of 1.06 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 40.42% While, its Average True Range was 0.55.

Raw Stochastic average of Cellebrite DI Ltd (CLBT) in the period of the previous 100 days is set at 77.49%, which indicates a major rise in contrast to 60.63% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 44.55% that was higher than 36.80% volatility it exhibited in the past 100-days period.